PMA/IDE Preemption Rule Would Not Be Revived By FDA Under Henney
This article was originally published in The Gray Sheet
Executive Summary
An FDA led by Jane Henney would not reissue a proposed rule on the subject of device preemption of state tort claims, the commissioner nominee told the Senate Labor and Human Resources Committee at her Sept. 2 confirmation hearing.